Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Hoffmann-La Roche
Pikavation Therapeutics, Inc.
Aminex Therapeutics, Inc.
Eli Lilly and Company
Shandong Suncadia Medicine Co., Ltd.
Terremoto Biosciences Inc.
Novartis
Avenzo Therapeutics, Inc.
Phoenix Molecular Designs
Novartis